​
​

Sonnet BioTherapeutics (SONN) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Sonnet BioTherapeutics Revenue Highlights

Latest Revenue (Y)

$147.81K

0

Main Segment (Y)

Better Burgers Fast Casual

Main Geography (Y)

United States

Sonnet BioTherapeutics Revenue by Period

Sonnet BioTherapeutics Revenue by Year

DateRevenueChange
2023-09-30$147.81K-57.76%
2022-09-30$349.94K-27.64%
2021-09-30$483.63K100.00%
2020-09-30--100.00%
2019-09-30$40.61M-1.98%
2017-12-31$41.43M-0.65%
2016-12-31$41.70M-1.64%
2015-12-31$42.40M100.00%
2014-12-31--100.00%
2013-12-31$17.50M-

Sonnet BioTherapeutics generated $147.81K in revenue during NA 2023, up -57.76% compared to the previous quarter, and up 0.36% compared to the same period a year ago.

Sonnet BioTherapeutics Revenue by Quarter

DateRevenueChange
2024-03-31--100.00%
2023-12-31$18.63K-50.00%
2023-09-30$37.26K1.10%
2023-06-30$36.85K1.11%
2023-03-31$36.45K-2.17%
2022-12-31$37.26K-40.63%
2022-09-30$62.75K1.10%
2022-06-30$62.07K-34.88%
2022-03-31$95.32K-26.56%
2021-12-31$129.80K-73.16%
2021-09-30$483.63K100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31--100.00%
2020-09-30$-5.68M100.00%
2020-06-30--100.00%
2020-03-31$5.68M100.00%
2019-12-31--100.00%
2019-09-30$9.65M-9.87%
2019-06-30$10.71M100.00%
2019-03-31-100.00%
2018-12-31--100.00%
2018-09-30$10.10M1.03%
2018-03-31$10.00M-6.80%
2017-09-30$10.73M8.78%
2017-03-31$9.86M-10.17%
2016-09-30$10.98M2.09%
2016-06-30$10.75M4.68%
2015-09-30$10.27M-4.83%
2015-06-30$10.79M12.12%
2014-09-30$9.63M39.12%
2014-06-30$6.92M330.81%
2013-09-30$1.61M-3.65%
2013-03-31$1.67M-5.68%
2012-09-30$1.77M-

Sonnet BioTherapeutics generated - in revenue during Q2 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Sonnet BioTherapeutics Revenue Breakdown

Sonnet BioTherapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 18
Corporate and Other$100.00K
Hooters Full Service$13.84M
Just Fresh Fast Casual$4.05M
Better Burgers Fast Casual$22.62M

Sonnet BioTherapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 18: Better Burgers Fast Casual (55.69%), Hooters Full Service (34.08%), Just Fresh Fast Casual (9.98%), and Corporate and Other (0.25%).

Quarterly Revenue by Product

Product/ServiceSep 19Jun 19Mar 19Dec 18Sep 18Jun 18
Hooters Full Service$2.89M$3.34M$3.35M$3.41M$3.39M$3.51M
Just Fresh Fast Casual$943.52K$1.01M$967.88K$926.05K$989.10K$1.06M
Corporate and Other$50.00K$25.00K$25.00K$25.00K$25.00K$25.00K
Better Burgers Fast Casual$5.82M$6.33M$5.86M$5.76M$5.69M$5.80M

Sonnet BioTherapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 19: Better Burgers Fast Casual (60.02%), Hooters Full Service (29.74%), Just Fresh Fast Casual (9.72%), and Corporate and Other (0.52%).

Sonnet BioTherapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 18
South Africa$5.83M
United States$31.93M
Europe$2.86M

Sonnet BioTherapeutics's latest annual revenue breakdown by geography, as of Dec 18: United States (78.62%), South Africa (14.34%), and Europe (7.04%).

Quarterly Revenue by Country

CountrySep 19Jun 19Mar 19Dec 18Sep 18Jun 18
South Africa$1.38M$1.35M$1.39M$1.50M$1.35M$1.47M
Just Fresh Fast Casual$943.52K-----
Hooters Full Service$2.89M-----
Corporate and Other------
Better Burgers Fast Casual$5.82M-----
Europe$634.41K$709.73K$652.73K$670.11K$707.51K$768.00K
United States$7.64M$8.65M$8.15M$7.95M$8.04M$8.16M

Sonnet BioTherapeutics's latest quarterly revenue breakdown by geography, as of Sep 19: United States (39.55%), Better Burgers Fast Casual (30.16%), Hooters Full Service (14.95%), South Africa (7.17%), Just Fresh Fast Casual (4.89%), and Europe (3.29%).

Sonnet BioTherapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
YSLakeShore Biopharma$687.20M$164.98M
SONNSonnet BioTherapeutics$147.81K-
CNSPCNS Pharmaceuticals--
ZVSAZyVersa Therapeutics--
IMMXImmix Biopharma--
ALLRAllarity Therapeutics--
EFTReFFECTOR Therapeutics--

SONN Revenue FAQ

What is Sonnet BioTherapeutics’s yearly revenue?

Sonnet BioTherapeutics's yearly revenue for 2023 was $147.8K, representing a decrease of -57.76% compared to 2022. The company's yearly revenue for 2022 was $349.94K, representing a decrease of -27.64% compared to 2021. SONN's yearly revenue for 2021 was $483.63K, representing an increase of 100.00% compared to 2020.

What is Sonnet BioTherapeutics’s quarterly revenue?

Sonnet BioTherapeutics's quarterly revenue for Q2 2024 was $0, a -100.00% decrease from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $18.63K, a -50.00% decrease from the previous quarter (Q4 2023), and a -50.00% decrease year-over-year (Q1 2023). SONN's quarterly revenue for Q4 2023 was $37.26K, a 1.10% increase from the previous quarter (Q3 2023), and a -40.63% decrease year-over-year (Q4 2022).

What is Sonnet BioTherapeutics’s revenue growth rate?

Sonnet BioTherapeutics's revenue growth rate for the last 3 years (2021-2023) was -69.44%, and for the last 5 years (2019-2023) was -99.64%.

What are Sonnet BioTherapeutics’s revenue streams?

Sonnet BioTherapeutics's revenue streams in c 18 are Corporate and Other, Hooters Full Service, Just Fresh Fast Casual, and Better Burgers Fast Casual. Corporate and Other generated $100K in revenue, accounting 0.25% of the company's total revenue Hooters Full Service generated $13.84M in revenue, accounting 34.08% of the company's total revenue Just Fresh Fast Casual generated $4.05M in revenue, accounting 9.98% of the company's total revenue Better Burgers Fast Casual generated $22.62M in revenue, accounting 55.69% of the company's total revenue

What is Sonnet BioTherapeutics’s main source of revenue?

For the fiscal year ending Dec 18, the largest source of revenue of Sonnet BioTherapeutics was Better Burgers Fast Casual. This segment made a revenue of $22.62M, representing 55.69% of the company's total revenue.